| Similar Articles |
|---|
 |
The Motley Fool
January 30, 2007
Ralph Casale |
Molecular Devices Acquired Successful integration of companies like Molecular Devices and improvement of operating margins in the pharmaceutical contract research business unit should reward shareholders well.   |
The Motley Fool
March 27, 2007
Ralph Casale |
Beckman-Coulter Gets Diagnostic An investor's look at instrument maker Beckman-Coulter's acquisition of medical diagnostic company Biosite. |
The Motley Fool
October 30, 2006
Ralph Casale |
Sigma-Aldrich Ekes Out Organic Growth Share buybacks and a dividend help offset some mixed news from this biotech/chemical company. Investors, take note. |
The Motley Fool
May 5, 2004
Brian Gorman |
Albany Molecular Gets Out-Outsourced Albany Molecular Research, provider of chemistry services to biotech and pharmaceutical clients, is suffering from the loss of business to low-cost competitors overseas. |
Bio-IT World
October 2005
Robert M. Frederickson |
Nanoflow Enhances LC Devices New flow control systems save time while offering higher precision and sensitivity that are key to better comparative proteomic data coming out of liquid chromatography-mass spectronomy applications as well as more traditional clinical and diagnostic analyses. |
Inc.
May 1, 2002
Kenneth Klee |
The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies... |
Chemistry World
March 31, 2014 |
Super separators First used in the mid-20th century, high performance liquid chromatography has matured and is now the workhorse of industrial analysis, while the pharmaceutical sector is one of the main customers of HPLC manufacturers. |
Financial Advisor
September 2004
Marla Brill |
A Biotechnology Fund On Sedatives Eaton Vance's Worldwide Health Sciences Fund manager Sam Isaly takes some nail biting out of biotech investing. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
| Knowledge@Wharton |
A New Approach to Valuing Biotech Stocks Enormous swings in biotechnology stock prices during the last few weeks show how difficult it is for investors to value biotech companies. It's important to understand the invisible potential locked up in the organizational structure of biotechnology companies... |
The Motley Fool
April 22, 2009 |
3 Stocks Hitting Low Notes This pharma stock has hit bottom. Is it ready to bounce? Take a look at: Pharmaceutical Product Development... |
Bio-IT World
December 15, 2004
John Russell |
Waters' Triumph of the Tiny 1.7-micron particle chemistry edges Waters Corp. forward in the race to supply the most powerful liquid chromatography (LC) equipment, giving a boost to proteomic research and biomarker discovery. |
The Motley Fool
February 19, 2009 |
2 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: BioMarin Pharmaceutical... National Instruments Corp... |
The Motley Fool
June 11, 2009 |
Today's 5-Star Movers A list of today's top-moving stocks from the Motley Fool five-star stock list. |
The Motley Fool
April 7, 2009 |
Today's 5-Star Movers A list of today's top moving stocks from the Motley Fool five-star stock list. |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector |
The Motley Fool
August 3, 2009 |
2 Stocks Hitting Low Notes UltraShort Real Estate ProShares and Genzyme have gone lower. Are they ready to bounce? |
The Motley Fool
December 27, 2007
Brian Orelli |
Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there. |
The Motley Fool
August 31, 2009 |
2 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Marvel Entertainment... Sinovac Biotech... |
The Motley Fool
December 6, 2011
Dan Caplinger |
4 Investments That Everybody Loves The crowd is jumping into some asset classes over others. Should you jump into these?: Gold... Corporate Bonds... Mid-cap U.S. Stocks... Small-Cap U.S. Growth Stocks... |
The Motley Fool
September 16, 2009 |
Today's 5-Star Movers Today's top-moving stocks from the Motley Fool five-star stock list: Keryx Biopharmaceuticals, Rogers Corp, etc. |
Knowledge@Wharton
March 26, 2003 |
Health Care Finance Industry Plagued by Lack of Funding, Focus In today's health care finance environment, early financing rounds are harder to fund and the market for initial public financings is dead, with no revival expected anytime soon. |
The Motley Fool
September 28, 2006
Ralph Casale |
A Second Sell-Off at Molecular Devices The company, which makes equipment used in drug development, is struggling with lumpy revenues. |
The Motley Fool
October 27, 2010
Ralph Casale |
Companion Diagnostics in Cancer Drug Development Diagnostic companies partnering with drug developers can make for an attractive investment segment. |
The Motley Fool
June 22, 2005
Brian Gorman |
Biotech's Global Agenda Bristol-Myers' recent outsourcing deal illustrates the global spread of biotech investments. |
InternetNews
November 5, 2010 |
VC Spending Plummets But Software Still Tops The third quarter was a disappointing one for venture capital investment but a good number of new software companies have little to complain about. |
The Motley Fool
August 26, 2009 |
3 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Bed Bath & Beyond... Sinovac Biotech... Dollar Tree Stores... |
The Motley Fool
July 22, 2004
Brian Gorman |
Stability for Covance? After a solid quarter, the drug development service company may have found a way to keep revenue consistent. |
The Motley Fool
July 25, 2011 |
West Pharmaceutical Services Earnings Preview West Pharmaceutical Services will unveil its latest earnings on Thursday, July 28. |
Bio-IT World
August 13, 2002
Jack Dolmat-Connell |
Cracking the Compensation Code The media and institutional shareholders have been jumping on the excessive executive compensation and stock options usage bandwagon as of late. Is executive pay in the life sciences out of control or too high? |
Job Journal
August 8, 2004
Rich Heintz |
Biotech's Winning Formula for Steady Job Growth Deep pockets are creating expanding opportunities and biotechnology is helping to put America back to work. |
The Motley Fool
August 28, 2009 |
3 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs. Take a look at: Medarex... Ebix... Select Comfort... |
The Motley Fool
June 2, 2009
Brian Orelli |
ASCO's Big Winner Despite the massive changes in value that some small-cap biotech companies have seen before and during this year's American Society of Clinical Oncology annual meeting, the big winner from the confab is actually large pharmaceutical companies. |
The Motley Fool
July 26, 2010
Tom Gardner |
A Disaster for Shareholders Two biotechnology stocks not worth the trouble. |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
The Motley Fool
April 29, 2011
Brian Orelli |
Show Us the Money, Drugmakers Drugmakers have cash and they aren't afraid to use it -- on themselves. |
The Motley Fool
March 12, 2009 |
2 Stocks Hitting High Notes These stocks are bucking the trend by hitting new highs. Take a look at: CV Therapeutics... AutoZone... |
Job Journal
July 16, 2006
Julia Hollister |
Biotech Boom The biotech field offers promising jobs in a profession that's expanding faster than you can spell biotherapeutics. |
The Motley Fool
January 31, 2007
Zoe Van Schyndel |
Health Care, Thinly Sliced Five new health-care-focused ETFs, the HealthShares family, provide increasingly specific ways to invest in health care. |
The Motley Fool
January 28, 2011
Luke Timmerman |
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars Biotech drugs will soon dominate the pharmaceutical industry, and Merck is playing catch-up. |
The Motley Fool
March 18, 2004
Brian Gorman |
The Drug Cost Conundrum While drug prices continue to climb, the public and its representatives in government are demanding cheaper pharmaceuticals. The industry is not likely to find cover in Medicare biotechnology. Instead, investors should look for drug makers that are finding ways to operate leaner and meaner. |
BusinessWeek
November 10, 2003
Arlene Weintraub |
Biotech Startups: Take Your Time Until products are close to approval, the public shouldn't share the risk |
The Motley Fool
February 27, 2009 |
3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: Fortune Brands... Martek Biosciences... EZCORP... |
The Motley Fool
November 16, 2006
Jim Fink |
The Best ETF for 2007: H&Q Life Sciences Investors H&Q Life Sciences, a health-care fund investing in one of the highest-growth sectors of the U.S. economy, is trading at a discount to NAV. Consequently, it's now primed to be the best-performing ETF for 2007. |
The Motley Fool
November 30, 2004
Charly Travers |
Picking Biotech's Winners Doing well as a biotech investor comes as much from avoiding the losers as picking the winners. A quick screen for making winning investment picks. |
The Motley Fool
June 22, 2009 |
Today's 5-Star Movers Maybe what glitters really is gold. |
Bio-IT World
June 15, 2003
Melissa Kruse |
Midwest/South Region Ohio: Outpacing U.S. in Bioscience Growth... Alabama: Sweet Home to Tech Tax Incentives... Kentucky: Investing Multimillions to Breed Bio Business... Minnesota: The 'Right Mix' of Talent and Funding... Tennessee: Pioneering Research Centers... Michigan: Teeming 'Life Sciences Corridor'... etc. |
Pharmaceutical Executive
November 1, 2011 |
Turbulent Waters: M&As 2011 The latest numbers in pharma deals reveals a sector in transition, where market volatility has sharply degraded the appetite for risk. |
The Motley Fool
October 5, 2006
Ralph Casale |
RNAi: Nobel Prize-Winning Biotechnology While drugs based on RNAi knockdown technology may have the potential to become the next big thing in biotechnology, they are still a long way from becoming FDA-approved marketable entities. But it's never too soon to start keeping an eye on the future. Investors, take note. |
The Motley Fool
December 16, 2003
David Nierengarten |
Biotech's Next Phase It's been a great year for biotech, but don't count on a repeat in 2004. Here are some tips for evaluating biotechnology and pharmaceutical stocks. |
